Bicycle Therapeutics (BCYC) Research & Development: 2018-2025
Historic Research & Development for Bicycle Therapeutics (BCYC) over the last 8 years, with Sep 2025 value amounting to $58.4 million.
- Bicycle Therapeutics' Research & Development rose 21.05% to $58.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $238.3 million, marking a year-over-year increase of 41.94%. This contributed to the annual value of $173.0 million for FY2024, which is 10.52% up from last year.
- Per Bicycle Therapeutics' latest filing, its Research & Development stood at $58.4 million for Q3 2025, which was down 17.74% from $71.0 million recorded in Q2 2025.
- In the past 5 years, Bicycle Therapeutics' Research & Development ranged from a high of $71.0 million in Q2 2025 and a low of $9.7 million during Q1 2021.
- Its 3-year average for Research & Development is $47.1 million, with a median of $44.7 million in 2023.
- Data for Bicycle Therapeutics' Research & Development shows a peak YoY soared of 125.50% (in 2023) over the last 5 years.
- Quarterly analysis of 5 years shows Bicycle Therapeutics' Research & Development stood at $13.0 million in 2021, then spiked by 90.79% to $24.7 million in 2022, then soared by 80.82% to $44.7 million in 2023, then increased by 11.37% to $49.8 million in 2024, then increased by 21.05% to $58.4 million in 2025.
- Its Research & Development stands at $58.4 million for Q3 2025, versus $71.0 million for Q2 2025 and $59.1 million for Q1 2025.